rs883844

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014905.5(GLS):​c.1854-1787T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.605 in 152,004 control chromosomes in the GnomAD database, including 28,456 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.61 ( 28456 hom., cov: 32)

Consequence

GLS
NM_014905.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.24

Publications

12 publications found
Variant links:
Genes affected
GLS (HGNC:4331): (glutaminase) This gene encodes the K-type mitochondrial glutaminase. The encoded protein is an phosphate-activated amidohydrolase that catalyzes the hydrolysis of glutamine to glutamate and ammonia. This protein is primarily expressed in the brain and kidney plays an essential role in generating energy for metabolism, synthesizing the brain neurotransmitter glutamate and maintaining acid-base balance in the kidney. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2012]
STAT1 (HGNC:11362): (signal transducer and activator of transcription 1) The protein encoded by this gene is a member of the STAT protein family. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. The protein encoded by this gene can be activated by various ligands including interferon-alpha, interferon-gamma, EGF, PDGF and IL6. This protein mediates the expression of a variety of genes, which is thought to be important for cell viability in response to different cell stimuli and pathogens. The protein plays an important role in immune responses to viral, fungal and mycobacterial pathogens. Mutations in this gene are associated with Immunodeficiency 31B, 31A, and 31C. [provided by RefSeq, Jun 2020]
STAT1 Gene-Disease associations (from GenCC):
  • autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Illumina, Orphanet
  • immunodeficiency 31B
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
  • Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.665 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GLSNM_014905.5 linkc.1854-1787T>C intron_variant Intron 17 of 17 ENST00000320717.8 NP_055720.3 O94925-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GLSENST00000320717.8 linkc.1854-1787T>C intron_variant Intron 17 of 17 1 NM_014905.5 ENSP00000317379.3 O94925-1

Frequencies

GnomAD3 genomes
AF:
0.605
AC:
91870
AN:
151886
Hom.:
28411
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.518
Gnomad AMI
AF:
0.661
Gnomad AMR
AF:
0.676
Gnomad ASJ
AF:
0.546
Gnomad EAS
AF:
0.352
Gnomad SAS
AF:
0.604
Gnomad FIN
AF:
0.694
Gnomad MID
AF:
0.503
Gnomad NFE
AF:
0.651
Gnomad OTH
AF:
0.593
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.605
AC:
91963
AN:
152004
Hom.:
28456
Cov.:
32
AF XY:
0.608
AC XY:
45163
AN XY:
74286
show subpopulations
African (AFR)
AF:
0.518
AC:
21443
AN:
41396
American (AMR)
AF:
0.676
AC:
10339
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.546
AC:
1892
AN:
3466
East Asian (EAS)
AF:
0.351
AC:
1817
AN:
5172
South Asian (SAS)
AF:
0.605
AC:
2915
AN:
4818
European-Finnish (FIN)
AF:
0.694
AC:
7328
AN:
10562
Middle Eastern (MID)
AF:
0.500
AC:
147
AN:
294
European-Non Finnish (NFE)
AF:
0.651
AC:
44235
AN:
67994
Other (OTH)
AF:
0.592
AC:
1247
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1820
3640
5461
7281
9101
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
764
1528
2292
3056
3820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.635
Hom.:
50567
Bravo
AF:
0.602
Asia WGS
AF:
0.496
AC:
1727
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
1.4
DANN
Benign
0.78
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs883844; hg19: chr2-191825769; API